Literature DB >> 12894615

Children with psychiatric disorders: the A1 Ain Community Psychiatric Survey.

Valsamma Eapen1, Mona Essa Jakka, Mohammed T Abou-Saleh.   

Abstract

OBJECTIVE: The prevalence of child psychiatric morbidity in the community is unknown in most developing countries, including those in the Arab region.
METHOD: An epidemiologic study was carried out to estimate the prevalence of psychiatric morbidity and to determine the sociodemographic correlates in a sample of children in the community, aged 6 to 18 years, in A1 Ain, United Arab Emirates (UAE).
RESULTS: We obtained a prevalence rate of 22.2% for overall morbidity, as classified in the DSM-1V, and 14.3% for those with significant dysfunction, with the most common diagnosis being mood disorders. Female sex, large family size, chronic life difficulties, family history of psychiatric disorder, and alcohol-related problems in a family member were significantly associated with DSM-IV diagnosis.
CONCLUSION: Although the prevalence and symptomatology in this Middle East community are similar to those in Western studies, none of these children had received professional help, suggesting serious deficiencies in mental health care services in the country.

Entities:  

Mesh:

Year:  2003        PMID: 12894615     DOI: 10.1177/070674370304800607

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  18 in total

1.  Prevalence of Psychiatric Disorders Among Turkish Children: The Effects of Impairment and Sociodemographic Correlates.

Authors:  Eyüp Sabri Ercan; Öznur Bilaç; Taciser Uysal Özaslan; Ulku Akyol Ardic
Journal:  Child Psychiatry Hum Dev       Date:  2016-02

2.  Correlates of Externalizing Behavior Symptoms Among Youth Within Two Impoverished, Urban Communities.

Authors:  Geetha Gopalan; Mary A Cavaleri; William M Bannon; Mary M McKay
Journal:  Child Youth Serv       Date:  2010-01-01

3.  Psychiatric disorders among adolescents from Lebanon: prevalence, correlates, and treatment gap.

Authors:  Fadi T Maalouf; Lilian A Ghandour; Fadi Halabi; Pia Zeinoun; Al Amira Safa Shehab; Lucy Tavitian
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-31       Impact factor: 4.328

Review 4.  Integration Between Mental Health-Care Providers and Traditional Spiritual Healers: Contextualising Islam in the Twenty-First Century.

Authors:  Nayeefa Chowdhury
Journal:  J Relig Health       Date:  2016-10

5.  Prevalence of child and adolescent psychiatric disorders in Santiago, Chile: a community epidemiological study.

Authors:  Benjamin Vicente; Flora de la Barra; Sandra Saldivia; Robert Kohn; Pedro Rioseco; Roberto Melipillan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-07-28       Impact factor: 4.328

6.  Gender Dsyphoria and Psychiatric Disorders in Children and Adolescents with Congenital Adrenal Hyperplasia.

Authors:  H Doktur; C Tanidir; H Güneş; T Aytemiz; G Durcan; H Önal; E Kutlu
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

7.  Clinical correlates of tourette's disorder across cultures: a comparative study between the United Arab Emirates and the United Kingdom.

Authors:  Valsamma Eapen; Mary M Robertson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

8.  Prevalence of psychological symptoms in Saudi secondary school girls in Abha, Saudi Arabia.

Authors:  Khalid S Al Gelban
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

9.  Psychiatric disorders in children attending a Nigerian primary care unit: functional impairment and risk factors.

Authors:  Mosunmola Tunde-Ayinmode; Olushola Adegunloye; Babatunde Ayinmode; Olatunji Abiodun
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2012-07-31       Impact factor: 3.033

10.  Screening for emotional and behavioural problems amongst 5-11-year-old school children in Karachi, Pakistan.

Authors:  Ehsan Ullah Syed; Sajida Abdul Hussein; Sadia Mahmud
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-04-21       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.